PRF1 and neoplasm: Blocking IL-9 signaling reduced the expression of granzyme B and perforin in human CD8+ T cells, and stimulation with recombinant IL-9 enhanced the cytotoxicity of tumor-specific mouse CD8+ T cells (66).